Literature DB >> 12586477

T cells as mediators of protective immunity against liver stages of Plasmodium.

Moriya Tsuji1, Fidel Zavala.   

Abstract

T cells from different subsets play a major role in protective immunity against pre-erythrocytic stages of malaria parasites. Exposure of humans and animals to malaria sporozoites induces (alphabeta CD8(+) and CD4(+) T cells specific for antigens expressed in pre-erythrocytic stages of Plasmodium. These T cells inhibit parasite development in the liver, and immunization with subunit vaccines expressing the respective antigenic moieties confers protection against sporozoite challenge. gammadelta and natural killer T cells can also play a role in protective immunity. Recent studies with mice transgenic for the alphabeta T-cell receptor have revealed the existence of complex mechanisms regulating the induction and development of these responses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12586477     DOI: 10.1016/s1471-4922(02)00053-3

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  33 in total

1.  Transcription status of vaccine candidate genes of Plasmodium falciparum during the hepatic phase of its life cycle.

Authors:  Myriam Bodescot; Olivier Silvie; Anthony Siau; Philippe Refour; Paco Pino; Jean-François Franetich; Laurent Hannoun; Robert Sauerwein; Dominique Mazier
Journal:  Parasitol Res       Date:  2004-02-12       Impact factor: 2.289

Review 2.  Clinical development of a novel CD1d-binding NKT cell ligand as a vaccine adjuvant.

Authors:  Neal N Padte; Xiangming Li; Moriya Tsuji; Sandhya Vasan
Journal:  Clin Immunol       Date:  2010-12-24       Impact factor: 3.969

3.  Distinct kinetics of effector CD8+ cytotoxic T cells after infection with Trypanosoma cruzi in naive or vaccinated mice.

Authors:  Fanny Tzelepis; Bruna C G de Alencar; Marcus L O Penido; Ricardo T Gazzinelli; Pedro M Persechini; Mauricio M Rodrigues
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

Review 4.  Reflections on early malaria vaccine studies, the first successful human malaria vaccination, and beyond.

Authors:  Jerome P Vanderberg
Journal:  Vaccine       Date:  2008-10-28       Impact factor: 3.641

5.  Helminth infection impairs the immunogenicity of a Plasmodium falciparum DNA vaccine, but not irradiated sporozoites, in mice.

Authors:  Gregory S Noland; Debabani Roy Chowdhury; Joseph F Urban; Fidel Zavala; Nirbhay Kumar
Journal:  Vaccine       Date:  2010-02-25       Impact factor: 3.641

6.  Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells.

Authors:  Melissa R van Dijk; Bruno Douradinha; Blandine Franke-Fayard; Volker Heussler; Maaike W van Dooren; Ben van Schaijk; Geert-Jan van Gemert; Robert W Sauerwein; Maria M Mota; Andrew P Waters; Chris J Janse
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-15       Impact factor: 11.205

7.  Advances and challenges in malaria vaccine development.

Authors:  Ruobing Wang; Joseph D Smith; Stefan H I Kappe
Journal:  Expert Rev Mol Med       Date:  2009-12-16       Impact factor: 5.600

Review 8.  The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology.

Authors:  K Artavanis-Tsakonas; J E Tongren; E M Riley
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

Review 9.  Genetically engineered, attenuated whole-cell vaccine approaches for malaria.

Authors:  Ashley M Vaughan; Ruobing Wang; Stefan H I Kappe
Journal:  Hum Vaccin       Date:  2010-01-29

10.  Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria.

Authors:  Nathan W Schmidt; Rebecca L Podyminogin; Noah S Butler; Vladimir P Badovinac; Brad J Tucker; Keith S Bahjat; Peter Lauer; Arturo Reyes-Sandoval; Claire L Hutchings; Anne C Moore; Sarah C Gilbert; Adrian V Hill; Lyric C Bartholomay; John T Harty
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.